| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 160.54B | 148.31B | 169.33B | 184.44B | 188.51B | 166.70B |
| Gross Profit | 21.20B | 18.54B | 22.08B | 25.16B | 26.06B | 19.80B |
| EBITDA | 10.71B | 7.97B | 11.52B | 15.05B | 16.61B | 9.46B |
| Net Income | 5.08B | 2.46B | 5.70B | 8.90B | 10.23B | 4.82B |
Balance Sheet | ||||||
| Total Assets | 148.85B | 152.37B | 149.15B | 152.09B | 148.79B | 143.62B |
| Cash, Cash Equivalents and Short-Term Investments | 15.47B | 23.25B | 15.35B | 16.49B | 16.77B | 15.77B |
| Total Debt | 8.92B | 8.52B | 9.45B | 9.87B | 10.74B | 16.21B |
| Total Liabilities | 42.04B | 43.22B | 42.33B | 47.53B | 51.92B | 54.68B |
| Stockholders Equity | 106.80B | 109.15B | 106.81B | 104.55B | 96.86B | 88.93B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 10.16B | 2.99B | 1.35B | 9.28B | -11.29B |
| Operating Cash Flow | 0.00 | 15.24B | 7.38B | 5.15B | 13.01B | -8.76B |
| Investing Cash Flow | 0.00 | -5.00B | -4.88B | -2.30B | -3.46B | -2.31B |
| Financing Cash Flow | 0.00 | -2.33B | -3.63B | -3.14B | -8.54B | 8.39B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥434.26B | 12.05 | ― | 3.26% | -6.84% | 4.65% | |
72 Outperform | ¥182.46B | 11.55 | 6.87% | 5.25% | -6.28% | 29.00% | |
62 Neutral | ¥371.52B | 11.21 | 6.16% | 2.99% | 0.55% | 20.51% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥186.09B | 19.21 | 7.36% | 3.42% | -17.96% | -43.14% | |
58 Neutral | ¥78.83B | 13.13 | ― | 3.70% | -2.40% | -8.59% | |
55 Neutral | ¥35.35B | 13.50 | ― | 5.02% | -12.42% | -56.79% |